Basic Science:

  1. Shin HS, Xu F, Bagchi A, Herrup E, Valentine C, Prakash A, Kulkarni H, Wilhelmsen K, Warren HS, Hellman J, Bacterial lipoprotein Toll-like receptor 2 agonists broadly modulate endothelial function and coagulation pathways in vitro and in vivo. J Immunol2011: 186(2): 1119-30.
  2. Elvington ME, Liszewski MK, Bertram PL, Kulkarni HS, Atkinson JP, A C3(H2O) recycling pathway of the intracellular complement system. J Clin Invest 2017: 127: 970-81.
  3. Kulkarni HS, Elvington M, Perng YC, Liszewski MK, Frakouh CS, Byers DE, Yusen RD, Lenschow DJ, Brody SL, Atkinson JP, Intracellular C3 protects human airway epithelial cells from stress-induced cell death. Am J Resp Cell Mol Biol 2019; 60: 144-57 (front page article).
  4. Elvington M, Liszewski MK, Liszewski AR, Kulkarni HS, Hachem RR, Mohanakumar T, Kim AHJ, Atkinson JP. Development and optimization of an ELISA to quantitate C3(H2O) as a marker of human disease. Front Immunol 2019; 10:703.
  5. Scozzi D, Ibrahim M, Liao F, Lin X, Hsiao HM, Hachem R, Tague L, Ricci A, Kulkarni HS, Huang HJ, Sugimoto S, Krupnick AS, Kreisel D, Gelman AE. Mitochondrial damage associated molecular patterns released by lung transplants are associated with primary graft dysfunction. Am J Transplant 2019;19:1464-77.

Clinical Science (top 5 within the last year):

  1. Kulkarni HS, Cherikh WS, Chambers DC, Garcia VC, Hachem RR, Kreisel D, Puri V, Kozower BD, Byers DE, Witt CA, Alexander-Brett J, Aguilar PR, Tague LK, Furuya Y, Trulock EP, Patterson AG, Yusen RD, Bronchiolitis-obliterans syndrome-free survival following lung transplantation – an analysis of the International Society of Heart and Lung Transplantation (ISHLT) registry. J Heart Lung Transplant 2019; 38(1): 5-16.
  2. Tague LK, Witt CA, Byers DE, Yusen RD, Aguilar PR, Kulkarni HS, Bain KB, Fester KA, Puri V, Kreisel D, Mohanakumar T, Trulock EP, Hachem RR. Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States. Ann Am Thorac Soc; 2019: 16:846-52.
  3. Tague LK, Byers DE, Hachem RR, Kreisel D, Krupnick AS, Kulkarni HS, Chen C, Huang HJ, Gelman AE. Impact of SLCO1B3 Polymorphisms on Clinical Outcomes in Lung Allograft Recipients Receiving Mycophenolic Acid. Pharmacogenomics J (Epub ahead of print).
  4. January SE, Fester KA, Bain KB, Kulkarni HS, Witt CA, Byers DE, Alexander-Brett J, Trulock EP, Hachem RR. Rabbit antithymocyte globulin for the treatment of chronic lung allograft dysfunction. Clin Transplant 2019; 33(10): e13708.
  5. Kulkarni HS, Tsui K, Sunder S, Ganninger A, Tague LK, Witt CA, Byers DE,Trulock EP, Nava R, Puri V, Kreisel D, Mohanakumar T, Gelman AE, Hachem RR.Pseudomonas aeruginosa and acute rejection independently increase the risk ofdonor-specific antibodies after lung transplantation. Am J Transplant 2019 (Epub ahead of print).

Reviews:

  1. Kasi PM, Tawbi HA, Oddis CV, Kulkarni HS, Serious adverse events associated with the use of rituximab: a critical care perspective. Critical Care2012: 31: 16: 231.
  2. Kulkarni HS, Bemiss BC, Hachem RR, Antibody-mediated rejection in lung transplantation. Curr Transpl Rep2015: 2: 316-23.
  3. Liszewski MK, Elvington ME, Kulkarni HS, Atkinson JP, Complement’s hidden arsenal: new insights and novel functions inside the cell. Mol Immunol2017: 84: 2-9.
  4. Kulkarni HS, Liszewski MK, Brody SL, Atkinson JP, The complement system in the airway epithelium – an overlooked host defense mechanism and therapeutic target? J Allergy Clin Immunol2018: 141: 1582-6.
  5. Kulkarni HS, Scozzi D, Gelman AE. Recent advances into the role of pattern recognition receptors in transplantation. Cell Immunol 2020 (Epub ahead of print).